Literature DB >> 26320140

Application of the DETECT algorithm for detection of risk of pulmonary arterial hypertension in systemic sclerosis: data from a Czech tertiary centre.

Tomas Soukup1, Radek Pudil2, Katerina Kubinova3, Lucie Hromadkova4, Jaroslav Dusek2, Marian Tosovsky3, Petr Bradna3, Zbynek Hrncir3, Jan Bures3.   

Abstract

OBJECTIVE: The early, simple and reliable detection of pulmonary arterial hypertension (PAH) in SSc (DETECT) study described a new algorithm for early detection of PAH in patients with SSc. The aim of this retrospective, single-centre, cross-sectional study was to apply a modified DETECT calculator in patients with SSc in the East Bohemian region, Czech Republic, to assess the risk of PAH and to compare these results with PAH screening based on the European Society of Cardiology/European Respiratory Society (ESC/ERS) 2009 guidelines.
METHODS: Sixty patients were recruited with a diagnosis of SSc (according to ACR criteria), aged 27-78 years. A modified DETECT algorithm using the modified parameter of (1.4 × right ventricle diameter)(2) in place of right atrium area was applied to all patients. Right heart catheterization (RHC) was performed in all patients with an estimated (by echocardiography) increased systolic pulmonary artery pressure ≥50 mm Hg in accordance with the ESC/ERS guidelines; however, RHC was not performed in patients solely recommended for RHC using the modified DETECT algorithm.
RESULTS: Using the modified DETECT calculator, 24/58 (41.4%) patients were recommended for RHC, compared with 14/58 (24.1%) when applying the ESC/ERS 2009 guidelines. PAH was diagnosed in 7/58 (12.1%) patients. During follow-up, PAH was diagnosed in six patients. Of these, four were modified DETECT score-positive for 2 years and all for 1 year before PAH diagnosis.
CONCLUSION: The modified DETECT algorithm detects all patients with PAH diagnosed according to ECS/ERS 2009 guidelines and RHC. Data of the 2-year follow-up indicate a possible positive predictive role for the modified DETECT calculator.
© The Author 2015. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  cardiovascular; clinical trials and methods; epidemiology; respiratory; scleroderma and related disorders

Mesh:

Year:  2015        PMID: 26320140     DOI: 10.1093/rheumatology/kev327

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  5 in total

1.  Update of screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension.

Authors:  Amber Young; Vivek Nagaraja; Mark Basilious; Mirette Habib; Whitney Townsend; Heather Gladue; David Badesch; J Simon R Gibbs; Deepa Gopalan; Alessandra Manes; Ronald Oudiz; Toru Satoh; Adam Torbicki; Fernando Torres; Vallerie McLaughlin; Dinesh Khanna
Journal:  Semin Arthritis Rheum       Date:  2018-10-14       Impact factor: 5.532

Review 2.  An Update on Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: a Review of the Current Literature.

Authors:  Sneha M Sundaram; Lorinda Chung
Journal:  Curr Rheumatol Rep       Date:  2018-02-27       Impact factor: 4.592

3.  High sensitivity and negative predictive value of the DETECT algorithm for an early diagnosis of pulmonary arterial hypertension in systemic sclerosis: application in a single center.

Authors:  Alfredo Guillén-Del Castillo; Eduardo L Callejas-Moraga; Gabriela García; José F Rodríguez-Palomares; Antonio Román; Cristina Berastegui; Manuel López-Meseguer; Enric Domingo; Vicente Fonollosa-Plá; Carmen Pilar Simeón-Aznar
Journal:  Arthritis Res Ther       Date:  2017-06-14       Impact factor: 5.156

Review 4.  Lung Involvements in Rheumatic Diseases: Update on the Epidemiology, Pathogenesis, Clinical Features, and Treatment.

Authors:  You-Jung Ha; Yun Jong Lee; Eun Ha Kang
Journal:  Biomed Res Int       Date:  2018-05-08       Impact factor: 3.411

5.  Pulmonary hypertension in systemic sclerosis: diagnosis by systematic screening and prognosis after three years follow-up.

Authors:  Verônica Silva Vilela; Marcio Macri Dias; Ângelo Antunes Salgado; Bruno Rangel Antunes da Silva; Agnaldo José Lopes; Elizabeth Jauhar Cardoso Bessa; Leonardo Palermo Bruno; Cláudia Henrique da Costa; Roger Abramino Levy; Rogério Rufino
Journal:  BMC Pulm Med       Date:  2021-07-29       Impact factor: 3.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.